Overview

Efficacy of Erenumab in Chronic Cluster Headache

Status:
Not yet recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy of erenumab in participants with chronic cluster headache.
Phase:
Phase 2
Details
Lead Sponsor:
Charite University, Berlin, Germany
Treatments:
Erenumab